Etiology Risk Factors and Screening Tips History Precipitating Factors and Complications Patient Assessment CEAP Classification Current Treatments Catheterbased Treatments Sclerotherapy and Sclerosing Agents ID: 700640
Download Presentation The PPT/PDF document "Epidemiology Venous Pathophysiology" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1Slide2Slide3
EpidemiologySlide4Slide5
Venous PathophysiologySlide6
EtiologySlide7
Risk Factors and Screening Tips Slide8
History, Precipitating Factors, and ComplicationsSlide9
Patient AssessmentSlide10
CEAP Classification Slide11
Current TreatmentsSlide12
Catheter-based TreatmentsSlide13
Sclerotherapy and Sclerosing AgentsSlide14
Physician-made Foam for SclerotherapySlide15
FDA-approved Polidocanol Injectable FoamSlide16
VANISH-2 EfficacySlide17
VANISH-2: Symptom Results – VVSymQ
™
ScoresSlide18
Safety Trial for Patients With PFOSlide19
Contraindications Slide20
Clinical OutcomesSlide21
Low DVT Risks of All OptionsSlide22
V
aricose
V
eins
Is C
osmetic
T
reatment
M
edically
N
ecessary
?Slide23
Take-Home MessagesSlide24
Take-Home Messages (cont)Slide25
AbbreviationsSlide26
ReferencesSlide27
References (cont)